Is Balaxi Pharmaceuticals stock a buy?

Yes, Balaxi Pharmaceuticals pays dividends. Last time was Wednesday 10th of August 2022 where the investors holding the stock on Friday 1st of July 2022 were paid INR0.5 per share. Over the last 1 times between 2022 and 2022, Balaxi Pharmaceuticals has paid INR0.5 with an average of INR0.5 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Balaxi Pharmaceuticals 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR18.71, you would have made a profit of INR86.68 per share or 463.28%

Yes, the average daily trading liquidity for Balaxi Pharmaceuticals is INR35 147 thousand. You should therefore be able to get in and out of your positions relatively fast.

Balaxi Pharmaceuticals has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.20, the company's ability to pay off the debt is normal. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Balaxi Pharmaceuticals to be low [0.45 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.